Nunzia Pharmaceutical Stock Net Income
| NUNZ Stock | USD 0.0001 0.00 0.00% |
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nunzia Pharmaceutical, as well as the relationship between them.
Nunzia Pharmaceutical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nunzia Pharmaceutical's valuation are provided below:Nunzia Pharmaceutical does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Nunzia |
Nunzia Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nunzia Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nunzia Pharmaceutical.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Nunzia Pharmaceutical on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Nunzia Pharmaceutical or generate 0.0% return on investment in Nunzia Pharmaceutical over 90 days. Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company More
Nunzia Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nunzia Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nunzia Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
Nunzia Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nunzia Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nunzia Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Nunzia Pharmaceutical historical prices to predict the future Nunzia Pharmaceutical's volatility.Nunzia Pharmaceutical Backtested Returns
We have found three technical indicators for Nunzia Pharmaceutical, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Nunzia Pharmaceutical are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Nunzia Pharmaceutical has perfect predictability. Overlapping area represents the amount of predictability between Nunzia Pharmaceutical time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nunzia Pharmaceutical price movement. The serial correlation of 1.0 indicates that 100.0% of current Nunzia Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Nunzia Pharmaceutical reported net income of (9.02 Million). This is 102.64% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 101.58% higher than that of the company.
Nunzia Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nunzia Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nunzia Pharmaceutical could also be used in its relative valuation, which is a method of valuing Nunzia Pharmaceutical by comparing valuation metrics of similar companies.Nunzia Pharmaceutical is currently under evaluation in net income category among its peers.
Nunzia Fundamentals
| Return On Asset | -2702.39 | |||
| Current Valuation | 87.59 M | |||
| Shares Outstanding | 434.52 M | |||
| Shares Owned By Insiders | 81.95 % | |||
| EBITDA | (9.02 M) | |||
| Net Income | (9.02 M) | |||
| Cash And Equivalents | 5.07 K | |||
| Total Debt | 139.96 K | |||
| Current Ratio | 0.20 X | |||
| Cash Flow From Operations | (86.78 K) | |||
| Earnings Per Share | (0.28) X | |||
| Beta | -2.57 | |||
| Market Capitalization | 24.88 M | |||
| Total Asset | 5.13 K | |||
| Net Asset | 5.13 K |
About Nunzia Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nunzia Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nunzia Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nunzia Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.